Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2009
04/02/2009WO2009039630A1 Optimized nucleic acid sequences for the expression of vb4-845
04/02/2009WO2008150150A3 Suppression of resistance in insects to bacillus thuringiensis cry toxins, using toxins that do not require the cadherin receptor
04/02/2009WO2008108649A3 Ace-inhibitory peptides from whey and methods for providing the same.
04/02/2009WO2008027337A3 Compositions for reducing cell adhesion to bubbles
04/02/2009WO2008013943A3 High-cell density fed-batch fermentation process for producing recombinant protein
04/02/2009WO2007015691A3 Methods and compositions for increasing longevity and protein yield from a cell culture
04/02/2009WO2006052807A3 A dna molecule of mortierella alpina lpaat homolog
04/02/2009WO2006041624A3 Nad biosynthesis systems
04/02/2009WO2006023495A3 Carotenoid hydroxylase enzymes
04/02/2009WO2006004910A3 Improved bispecific antibodies
04/02/2009WO2005097169A3 Novel immunotherapy
04/02/2009WO2005054433A3 A novel “cleave-n-read” system for protease activity assay and methods of use thereof
04/02/2009WO2005044974A3 Cell death-related nucleases and their uses
04/02/2009WO2005039500A3 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”)
04/02/2009WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17
04/02/2009US20090088558 Tumor necrosis factor specific antibody hybrid for use in treatment and prevention of autoimmune, rheumatoid arthritic, graft rejection and graft-versus-host disorder
04/02/2009US20090088556 Fusion antigen used as vaccine and method of making them
04/02/2009US20090088555 44 Human Secreted Proteins
04/02/2009US20090088370 Method for Improved Isolation of Recombinantly Produced Proteins
04/02/2009US20090087905 VEGF-D polynucleotides and methods of use
04/02/2009US20090087883 Novel expression vector with enhanced gene expression capacity and method for using the same
04/02/2009US20090087882 Protein secretion in eukaryotic cells
04/02/2009US20090087881 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
04/02/2009US20090087880 PROCESS AND GENES FOR EXPRESSION AND OVEREXPRESSION OF ACTIVE [FeFe] HYDROGENASES
04/02/2009US20090087879 Method for the production of a lysate used for cell-free protein biosynthesis
04/02/2009US20090087874 Glucose dehydrogenase and production thereof
04/02/2009US20090087865 Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus
04/02/2009US20090087861 Chimeric Tymovirus-like Particles and Process Thereof
04/02/2009US20090087836 Cytokines; fab fragments; fv fragments; monoclonal antibodies
04/02/2009US20090087832 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
04/02/2009US20090087478 Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
04/02/2009US20090087458 Activatable recombinant neurotoxins
04/02/2009US20090087448 Stable Immunoprophylactic and Therapeutic Compositions Derived From Transgenic Plant Cells and Methods for Production
04/02/2009US20090087439 Compositions and methods for diagnosing or treating psoriasis
04/02/2009US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof
04/02/2009US20090087421 Novel Recombinant Staphylokinase Derivatives and the Preparations and Applications thereof
04/02/2009US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors
04/02/2009CA2700986A1 Anti-glypican-3 antibody having improved kinetics in plasma
04/02/2009CA2700815A1 Optimized nucleic acid sequences for the expression of vb4-845
04/02/2009CA2700701A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr
04/02/2009CA2700394A1 Modified antibody constant region
04/02/2009CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same
04/01/2009EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use
04/01/2009EP2042596A1 Polypeptides involved in immune response
04/01/2009EP2042594A1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
04/01/2009EP2042518A2 Dual specificity antibodies and methods of making and using
04/01/2009EP2042512A2 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
04/01/2009EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
04/01/2009EP2041296A2 Method for producing stable mammalian cell lines producing high levels of recombinant proteins
04/01/2009EP2041295A2 Methods for arbitrary peptide synthesis
04/01/2009EP2041267A2 Compositions and methods for enhancing glycerol utilization
04/01/2009EP2041170A1 Method for producing insulin analogs having a dibasic b chain terminus
04/01/2009EP1597379B1 Endomannosidases in the modification of glycoproteins in eukaryotes
04/01/2009EP1549341B1 Tissue factor targeted antibodies as anticoagulants
04/01/2009EP1368486A4 Formulations for il-11
04/01/2009EP1119623B1 Mage-a3 peptides presented by hla class ii molecules
04/01/2009EP0970207B1 Heregulin variants
04/01/2009CN101397581A Method for extracting fishskin collagen polypeptide from fish wastes
04/01/2009CN101397564A Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors
04/01/2009CN101397341A Lipase inhibitor from natto, preparation method and use thereof
04/01/2009CN101397333A De-hydroxyl vancomycin, preparation method thereof, medicament composition and use thereof
04/01/2009CN101396378A Nano gene peptides products and preparation method and use thereof
04/01/2009CN101396065A Microecology preparation using bovine placenta protein as natural nutrient factor and preparation method thereof
04/01/2009CN100473725C Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor
04/01/2009CN100473663C Heterologous expression of neisserial proteins
03/2009
03/31/2009US7511129 Genetically engineered DNA transfer vector comprising a polynucleotide sequence that encodes a toxin comprising an insecticidal fragment
03/31/2009US7511123 Binding to antigen; controlling concentration
03/31/2009US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions
03/31/2009US7511024 Factor VII or VIIA-like molecules
03/31/2009US7510861 Gluconate dehydratase
03/31/2009US7510860 Xylanases with enhanced thermophilicity and alkalophilicity
03/31/2009US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders
03/31/2009US7510854 Using transgenic gramnegative bacteria as biorecator for fermentation of methione and lysine for use in medicine, cosmetics and animal feeds
03/31/2009US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2
03/31/2009US7510852 Biosynthetic genes and host cells for the synthesis of polyketide antibiotics and method of use
03/31/2009US7510831 Expression vector comprising nucleotide sequences coding phytase for use in transformation and expression in aspergillus; enhancing nutrient quality of animal feeds
03/31/2009US7510719 Methods of producing influenza vaccine compositions
03/31/2009US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders
03/31/2009US7510709 Method of treating inflammatory disease by inhibition of IL-17 production
03/31/2009CA2216126C Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
03/31/2009CA2192467C Calcium binding recombinant antibody against protein c
03/31/2009CA2066204C Cystic fibrosis gene
03/26/2009WO2009038841A2 Portable, temperature and chemically inducible expression vector for high cell density expression of heterologous genes in escherichia coli
03/26/2009WO2009038195A1 Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
03/26/2009WO2008148072A3 Disease-associated genetic variations and methods for obtaining and using same
03/26/2009WO2008058269A3 Compounds and methods for modulating protein trafficking
03/26/2009WO2005117969A3 Solution phase biopanning method using engineered decoy proteins
03/26/2009WO2005077046A3 A composition and method of treating mastitis
03/26/2009WO2005072457A3 Humoral response to hip1 in cancer
03/26/2009US20090082548 System and method for production of antibodies in plant cell culture
03/26/2009US20090082299 Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells
03/26/2009US20090082297 Compositions and Methods for Regulating Gene Expression
03/26/2009US20090082274 Collections of repeat proteins comprising repeat modules
03/26/2009US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/26/2009US20090082264 123 Human Secreted Proteins
03/26/2009US20090082254 Coupling of Polypeptides at the C-Terminus
03/26/2009US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids
03/26/2009US20090081788 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
03/26/2009US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
03/26/2009US20090081764 Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay